
SABELA
🇫🇷 France
Unclaimed Profile
This Company Profile has not yet been claimed. To claim the profile, please click here.
Some Numbers About SABELA
Standards (1)
Facilities / Offices (1)
About (SABELA)
SABELA is a prominent pharmaceutical company with a strong foothold in the fields of Gastroenterology and Women's Health. With a focus on innovation and patient well-being, SABELA delivers a range of market-leading medicines that cater to the needs of gastroenterologists, specialists, and patients across the United States. Their product portfolio includes SUFLAVE™, SUTAB®, SUPREP® Bowel Prep Kit, and MIUDELLA®, the first low-dose hormone-free intra-uterine device (IUD) in the U.S. in over 40 years. SABELA's commitment to advancing healthcare is evident through their dedication to research and development, as well as their strategic partnerships in the pharmaceutical industry.
Founded in 1999, SABELA Consulting has established itself as a reputable player in the recruitment and consulting arena, operating across Africa. Their team of professional consultants offers expertise in recruitment, headhunting, and contract management, providing clients with tailored solutions to meet their staffing needs. The company's emphasis on governance, professionalism, and cost-effective services has led to substantial growth and client satisfaction over the years. SABELA Consulting's commitment to quality work and client preferences underscores their dedication to delivering exceptional results in the recruitment sector.
As a company with a rich history of innovation and a commitment to improving patients' lives, SABELA Pharmaceuticals continues to make strides in the pharmaceutical industry. Their mission is to enrich the health and well-being of women through the development of next-generation therapeutics with innovative features. With a strong presence in Gastroenterology and Women's Health, SABELA stands out for its unique approach to healthcare and its focus on providing value to patients and physicians. Moving forward, SABELA is poised to continue leading the way in pharmaceutical innovation and making a positive impact on the healthcare landscape.